HomePCVX • NASDAQ
add
Vaxcyte Inc
Previous close
$73.02
Day range
$71.63 - $74.48
Year range
$58.10 - $121.06
Market cap
8.99B USD
Avg Volume
1.17M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 162.17M | 33.28% |
Net income | -137.08M | 24.18% |
Net profit margin | — | — |
Earnings per share | -1.02 | 44.09% |
EBITDA | -159.30M | 18.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.75B | 61.74% |
Total assets | 3.51B | 149.40% |
Total liabilities | 205.50M | 22.72% |
Total equity | 3.31B | — |
Shares outstanding | 128.76M | — |
Price to book | 2.76 | — |
Return on assets | -11.47% | — |
Return on capital | -11.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -137.08M | 24.18% |
Cash from operations | -111.40M | 13.52% |
Cash from investing | -557.17M | -3,900.92% |
Cash from financing | 4.91M | 79.41% |
Net change in cash | -662.31M | -348.47% |
Free cash flow | -89.47M | 1.66% |
About
Founded
2013
Headquarters
Website
Employees
414
